Skip to main content

Table 2 Comparison of acne variables in case and control groups during one and three months

From: The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial

 

Baseline

After 1 month

After 3 months

Change%

p value

Mean

SD

Mean

SD

Mean

SD

Baseline to Month1

Baseline to Month3

Month1 to Month3

Volume

Control

134.45

78.88

99.86

40.97

–

–

− 18.12%

0.112

–

–

Case

131.90

63.04

84.23

44.41

–

–

− 33.87%

0.026

–

–

Area

Control

11.43

5.52

9.36

3.69

–

–

− 14.97%

0.069

–

–

Case

12.66

5.68

8.43

3.87

–

–

− 30.03%

0.033

–

–

Depth

Control

10.86

1.57

10.14

0.90

–

–

− 5.06%

0.310

–

–

Case

9.86

1.07

9.14

0.90

–

–

− 6.88%

0.047

–

–

Epidermal thickness

Control

67.71

8.69

78.28

7.91

83.75

21.03

+ 16.17%

0.001

+ 33.75%

0.158

+ 12.91%

0.360

Case

66.43

9.91

85.43

12.82

85.25

8.46

+ 30.24%

0.009

+ 41.95%

0.064

+ 9.50%

0.378

Dermal thickness

Control

687.71

110.53

801.14

111.90

893.75

47.89

+ 17.89%

0.033

+ 29.59%

0.042

+ 10.40%

0.119

Case

629.43

111.49

965.57

155.36

981.25

78.57

+ 58.81%

0.008

+ 61.27%

0.002

+ 11.11%

0.101

Complete thickness

Control

755.43

112.47

879.43

113.30

977.50

66.14

+ 17.65%

0.028

+ 29.75%

0.045

+ 29.75%

0.093

Case

695.86

114.65

1051.00

161.84

1066.50

71.39

+ 55.45%

0.007

+ 58.99%

0.001

+ 10.89%

0.101

  1. p numbers based on paired t test